M3D Technologies’ Post

⚕ 6 healthtech ideas VCs want you to pitch in 2024 ⚕ The article on Sifted discusses the fluctuating relationship between venture capitalists (VCs) and the healthtech sector. While biotech remains attractive to investors, digital health startups have experienced a downturn in funding. Despite this, VCs are optimistic about areas like AI and preventative care, which are seen as solutions to challenges in healthcare systems. ⚕ The article features insights from six VCs on promising healthtech ideas for 2024.Here is the list of these healthtech ideas and the insights from the 6 VCs in summary form:- 1) D2C Health Diagnostics - insight from Will Gibbs, Octopus Ventures.   - There is potential for startups to offer affordable annual health assessments using AI and advanced diagnostics.   - A subscription model could support continuous health monitoring and increase accessibility through partnerships with insurers and employers. 2) AI-driven Business Intelligence for Pharma - insight from Daria Gherghelas, Speedinvest   - AI can revolutionize commercial intelligence in pharma by synthesizing data on competition and market changes.   - Such platforms could provide cost-effective insights, aiding in managing drug portfolios and clinical trials. 3) AI Tools for Hospitals - insight from William McQuillan, Frontline Ventures.   - AI tools could enhance patient triaging, manage data, scheduling, and billing, and offer personalized medicine.   - AI can help hospitals cope with increased patient demand due to an ageing population. 4) Diagnosis and Care for Neurodegenerative Diseases - insight from Lavanya Bhamidipati, InHealth Ventures.   - Healthtech companies can address the economic burden of diseases like Parkinson's and Alzheimer's.   - Solutions include early diagnosis, symptom monitoring, and coordinated care to reduce costs and improve patient outcomes. 5) Health Management Apps - insight from Michiel Kotting, Northzone.   - Developing apps to help patients manage their health can bypass the slow regulatory process of AI in medical systems.   - This approach is attractive for individuals interested in longevity and managing chronic conditions. 6) Tools for Lower-Trained Healthcare Professionals - insight from Yahel Halamish, Nina Capital.   - Tech tools can empower lower-trained healthcare workers to provide better care.   - Startups focusing on these tools can reduce the burden on healthcare professionals and improve patient monitoring and care actions. ⚕ For further details, you can read the full article on Sifted 👇 https://lnkd.in/etsMAbBF #healthtech #health #tech #AI #preventative_care #healthcare #startups #founder #VCs #venturecapital #doctors #technologist #innovation #innovator #SMEs #entrepreneur #entrepreneurship #hospitals #neurodegenerative #diseases #patient_care #investor #investment #pitching #future

**Calling all healthcare innovators! ** Join us for the InnovatorMD Startup Showcase on May 16th (5:00 PM - 6:30 PM PST) - a virtual event packed with inspiration and valuable insights. Keynote: Mastering the AI Pitch Deck with Irina Kukuyeva, Ph.D. (she/her) 📌 Learn the Top 5 Pitch Deck Mistakes from a renowned AI expert. 📌Gain strategies to craft a winning presentation and secure funding. 📌Dr. Kukuyeva, a powerhouse in AI with over a decade of experience, will share her expertise. Startup Showcase: Meet the Disruptors 📌Find Gumption: Omar Shaker, MD brings next-gen mental health solutions to busy professionals. 📌Recoup Health: Vivek Narayan showcases their innovative approach to integrative rehabilitation. Bonus Keynote: Valuation Strategies for Startups 📌Christian A., MD, Ph.D., MBA unveils the secrets of fair valuation for startups. 📌Learn about convertible notes, equity rounds, and SMART Cap Tables. 📌Ask your Cap Table or questions during the session! Don't miss this chance to connect, learn, and be part of the healthcare revolution! RSVP now: https://lnkd.in/gxZxt-ga Uli K. Chettipally, MD., MPH., Suzy Engwall, Lavinia Herbei, MD, MBA, Nila Rafiq, MD, MBA, Suchet Sarda MD, FACP, MMM, CPE, Dominique Kim, MPH #InnovatorMD #HealthcareInnovation #StartupShowcase #AI #MentalHealth #Rehabilitation #Valuation #Investment P.S. Share this post with your network and invite fellow healthcare innovators!

Big Boost for European Health Tech in Q3 2024 Despite a tough year for many startups, European health tech made a strong comeback in Q3, raising $2bn in funding! Oncology startups, like CatalYm GmbH and Myricx Bio, attracted major investments, showing the growing impact of AI in healthcare. Even though overall startup funding in Europe dropped 35% compared to last year, health tech and AI-powered solutions are proving to be bright spots. With early-stage investments staying strong and a focus on AI and biotech, the European startup ecosystem is set for more growth in 2025! Read more here: https://lnkd.in/efXyJYG8 #HealthTech #Startups #AI #Oncology #Innovation #EuropeStartups #Biotech #Investment

The Latest Startup Funding Buzz 1.    OncoveryCare (formerly VivorCare) closed an oversubscribed $4.5 million seed financing to launch its novel cancer survivorship care model that provides personalised, longitudinal care for cancer survivors. 2.    YourSix, a leader in cloud physical security solutions, raised $10.5 million in Series A funding. They are a Physical Security as a Service (PSaaS) provider. 3.    Better Health, a medical supply and support provider built on peer-to-peer connection, secured $14 million in a strategic funding. They are revolutionising healthcare delivery for chronic conditions. 4.    Daisy, a home and small business technology installation and services company, secured $11 million in their Series A funding round. 5.    Nexus a zero-knowledge cryptography company, raised $25 million in a Series A funding round. They envision scientific breakthroughs in verifiable computation. 6.    Canary Speech, a leading AI-powered voice biomarker health tech company, secured $13 million in a Series A funding. They use real-time patented vocal analysis to screen for mental health and neurological disorders. 7.    Pyte, the secure computation platform for data-first global enterprises, raised $5 million in additional capital, and $12 million in total. Pyte is a secure data collaboration solutions provider. 8.    Apex - Spacecraft Manufacturing company, secured $95 million in their Series B funding round. 9.    Learn to Win raised an oversubscribed $30 million in Series A funding. This active learning platform streamlines training for high-performance teams. 10. Canary Technologies, closed a $50 million Series C funding round. They are modernising the hotel tech stack with the first mobile web end-to-end Guest Management System and Digital Authorisations solutions. Startups and funding alert on WhatsApp: https://lnkd.in/dDmwtnNH #ai #funding #startups #appdevelopment #ecomapps #datingapps #appscrip #telemedicine #sasigeorge #transportation

Do we need more startups working to bridge the gap between academic research and commercialization and speed up time to market? According to US operators and investors within digital health, we do. In fact they see a definite lack in this 'process niche', if you will. I find the idea fascinating. While I do think there are some processes in research and especially validating research, it can be tricky to speed up, we're obviously so used to focusing on the individual end product that we might not see the opportunity to do something on a more systemic level - and build solutions towards that end - as an opportunity in itself. What do you think? #startup #academia #research #commercialization #gotomarket https://lnkd.in/duC3bF2H

There’s an adage in VC circles that a company will raise money as long as it slaps an 'AI' sticker on its packaging. The trend is especially pronounced in healthcare, a sector that has struggled to automate its processes and is looking to make up for lost time. NY’s market for DH companies in the AI rush has exploded. As of Oct, VCs have already invested >$1B in NY-based health companies, up from $670M in all of 2023 and $530M in 2022, per PitchBook. The exuberance is all the more notable bc VC investment in other sectors has slowed in recent years. While pharma companies are seeing a colder VC market compared to 2 or 3 yrs ago, an emerging field of AI-backed therapeutics startups is drawing capital hand over fist. The stampede isn’t limited to biotech. Companies are applying AI to virtually every aspect of healthcare–a sector that has remained stubbornly manual even as automation in manufacturing and simple computing powered many of the biggest industries of the last century. That’s true for both biotech and the mundane back-office functions of providers, but for different reasons. In the case of Rx discovery, identifying the molecules that affect diseases is like finding a needle in a haystack, involving massive amounts of trial and error, time and money. On the admin side, the variability of human health and the complexity of medical billing that accompanies it has been a morass too thick for traditional computing to crack. That is still more or less true in the case of Rx development. Hype around the power to analyze vast sums of data using LLMs and other types of AI has seeped into almost every sector. Its turning point in healthcare may have been in 2021 when Google unveiled the results of AlphaFold, a software using huge datasets to predict the shape of proteins, a key function in the discovery of new drugs. That year saw an explosion of VC funding in AI-backed health startups, with $1.9B invested in NY companies, ~4X the years before and after. In September, Chai Discovery, an Rx discovery startup, raised $30M in seed funding led by Thrive Capital. Chai is part of a subset of startups marketing predictive software for therapeutics companies to apply, rather than developing drugs itself. The sector is hoping to make it cheaper and faster to bring a drug thru clinical trials to market, which currently takes ~decade and $2B on avg. Some investors are sober about the limits of AI’s power to spur an Rx revolution. Predicting protein shape is just one of 100s of stages in the drug discovery process. And Investors have a tendency to overgeneralize success stories. The biggest cash cows are the companies applying advanced computing to the admin functions of a doctor’s office–which text-based LLMs are particularly adept at tackling. Nirvana, a NY startup that aims to use AI to process insurance claims, raised $24M in a Series A in September. Spring Health, which claims to use AI to improve patient referrals, closed a $100M Series E in August

𝗙𝗿𝗼𝗺 £𝟮.𝟮𝗠 𝗘𝗨 𝗳𝘂𝗻𝗱𝗶𝗻𝗴 𝘁𝗼 £𝟰𝟱𝗠 𝗶𝗻 𝗲𝗰𝗼𝗻𝗼𝗺𝗶𝗰 𝗶𝗺𝗽𝗮𝗰𝘁 - 𝗵𝗲𝗿𝗲'𝘀 𝗵𝗼𝘄 𝟱𝟱𝟬+ 𝗛𝗲𝗮𝗹𝘁𝗵𝗧𝗲𝗰𝗵 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗴𝗿𝗲𝘄 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝘁𝗵𝗲 𝗦𝗜𝗚𝗛𝗧 𝗽𝗿𝗼𝗴𝗿𝗮𝗺 Had an inspiring meeting with Phil Jewell today who shared a powerful story about innovation funding... 🌟 Under Phil's leadership, the SIGHT Programme at University of Portsmouth showcased what's possible when you back innovation in healthcare. With an initial £2.2M EU investment, the programme enabled £45M of economic impact in the UK. But the numbers only tell part of the story. He built a thriving community of 550+ healthtech companies, from startups to scale-ups, spanning: * AI-driven diagnostics * Surgical innovations * Mental health platforms * Remote patient monitoring * Genomic sequencing solutions The secret to success? Three key elements: 1. Research funding - helping companies secure grants to develop new technologies 2. Clinical partnerships - connecting innovators with healthcare professionals 3. Academic collaboration - facilitating access to university expertise and facilities This wasn't just about funding - they created an ecosystem where innovation could thrive. His team helped 8 new HealthTech companies start up in Portsmouth and facilitated over £25M in investment rounds. Sadly, while SIGHT's funding has ended, the need for this type of support hasn't. There's still a significant gap in startup HealthTech support across Hampshire, Dorset, and Surrey. Would love to hear from others working to bridge this gap. What support do you think HealthTech start ups need most?

Funding Update - USA - Bio tech Sector got significant funding #XairaTherapeutics: Secured over $1 billion from lead investors #ArchVenturePartners and #ForesiteCapital, among others. Led by founding CEO Marc Tessier-Lavigne, the biotech firm aims to leverage AI models for drug discovery. #Augment: Raised $227 million in Series B funding, with support from investors such as #SutterHillVentures and #IndexVentures. The AI coding assistance startup helps developers enhance their productivity. #Rippling: Closed a $200 million round, valuing the HR startup at $13.5 billion. Led by #Coatue, the funding included a $590 million secondary offering for employees. Rippling offers a workforce management platform integrating HR, IT, and finance. #Cognition: Secured $175 million in investment led by #FoundersFund, valuing the AI coding startup at $2 billion. Cognition's AI-powered coding assistant, Devin, aims to streamline software development processes. #Endeavor BioMedicines: Raised $133 million in Series C funding led by #AyurMaya. Specializing in treatments for idiopathic pulmonary fibrosis, the San Diego-based biotech company has now raised nearly $300 million since its inception. #ThreatLocker: Closed a $115 million Series D round led by #GeneralAtlantic. The cybersecurity startup offers zero trust endpoint security solutions and has experienced significant growth in revenue and workforce. #Lumeris: Raised $100 million in investment led by #DeerfieldManagement and #EndeavorHealth. The St. Louis-based company develops a healthcare spending platform, having raised a total of $325 million since its founding in 2000. #Perplexity AI: Announced a $62.7 million round, with plans for a larger raise aiming to boost its valuation to $2.5 billion to $3 billion. Led by #DanielGross, the AI search engine startup is actively engaging investors for additional funding. #Midi Health: Closed a $60 million Series B round led by #EmersonCollective. The Los Altos-based virtual care clinic for women has raised a total of $100 million since its establishment in 2021. #Givebutter: Secured a $50 million strategic growth investment led by #BVPForge. The Austin-based platform for nonprofit fundraising and CRM has raised $57 million since its inception in 2016. #SynOx Therapeutics: Dublin-based biotechnology research company focusing on giant cell tumors raised a $75 million Series B round. Follow me for updates like this!

5 Startups That Secured Significant Funding in June June 2024 saw several innovative startups secure substantial funding, with investments ranging from $4.8 million to $28 million. These capital raises highlight the continued investor interest in cutting-edge technologies and solutions: ✅Eyebot raised $6 million for AI-powered kiosks providing rapid vision exams ✅Canary Speech secured $13 million for AI vocal analysis to screen for health disorders ✅Butterflies AI obtained $4.8 million for a social media platform enabling human-AI interactions ✅Particle raised $10.9 million for an AI-driven news reader promoting diverse perspectives ✅LD Carbon (LDC) secured $28 million for recycling end-of-life tires into new materials These funding rounds demonstrate the potential of AI and innovative technologies to transform healthcare, social media, news consumption, and sustainability efforts. At GlenFlow, we're excited to see such significant investments in diverse applications of AI addressing real-world challenges, underscoring sustainable practices across various industries. We look forward to following their progress and the positive impact. Read more: https://lnkd.in/e8SZ9jbk #StartupFunding #AIInnovation #HealthTech #SocialMediaTech #NewsMedia #Sustainability #VentureCapital #TechStartups #InnovationInvestment #EmergingTechnologies

👋 Meet the #foundingteam of VIA HealthTech and say hello to Manuel Gremblewski and Lion Langer, who are currently taking part in our #BerlinerStartupStipendium Science & Startups for #Future program 👏 The team is being incubated within the cluster #Healthcare x #Prevention – Responding to Today’s Health Challenges. 💬 VIA HealthTech is the first virtual assistant in psychotherapy. Using the latest AI technology, we support psychotherapists by automatically documenting session notes and creating psychological reports in a matter of seconds. This gives us valuable time for therapy instead of administrative tasks. 💫 Science & Startups supports early stage founders who are planning to implement their innovative, knowledge-driven, science- and/or technology-based business ideas in a team. Within the #BerlinerStartupStipendium they get the resources to develop solutions for the pressing challenges of our time. ✨Follow for more and get to know all teams and their #startup #ideas throughout the next weeks. Do you want to join one of our startup teams? Some of them are still looking! 👉 Get on our match'em platform to connect with top university talent, find co-founders, and build your dream team! Link in comments Science & Startups Freie Universität Berlin Humboldt-Universität zu Berlin Technische Universität Berlin Charité - Universitätsmedizin Berlin Europäischer Sozialfonds (ESF) Investitionsbank Berlin (IBB) Senatsverwaltung für Wirtschaft, Energie und Betriebe Profund Innovation - Freie Universität Berlin  Humboldt-Innovation Centre for Entrepreneurship, TU Berlin Berlin Institute of Health in der Charité NFUSION Entrepreneurs Network Freie Universität Berlin Berlin University Alliance #health #therapy #psychology #automation #virtualassistant #aitech #healthtech #startups #innovation #gründen #pioneers #vision #berlin #founding #team #funding #launch #start #tonewbeginnings #business #visionary #highpotential #spark